Ayijiang Yisimayi

机构：Boston Children's Hospital · ORCID：0000-0003-0648-1864

发表论文 53 篇 · 总被引 8446 次 · h-index 28

代表论文

• Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure (2023 · The Lancet Infectious Diseases · 被引 402)
• Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting (2023 · Nature · 被引 275)
• Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86 (2023 · The Lancet Infectious Diseases · 被引 177)
• Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1 (2024 · Nature · 被引 147)
• Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455–456 synergistically enhances antibody evasion and ACE2 binding (2023 · PLoS Pathogens · 被引 120)
• A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2 (2024 · Protein & Cell · 被引 41)